Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03139331
Title PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications

Ewing sarcoma

osteosarcoma

rhabdomyosarcoma

sarcoma

Therapies

Irinotecan + Pazopanib + Temozolomide

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.